These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 23044601)
1. Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study. Mahurkar S; Moldovan M; Suppiah V; Sorosina M; Clarelli F; Liberatore G; Malhotra S; Montalban X; Antigüedad A; Krupa M; Jokubaitis VG; McKay FC; Gatt PN; Fabis-Pedrini MJ; Martinelli V; Comi G; Lechner-Scott J; Kermode AG; Slee M; Taylor BV; Vandenbroeck K; Comabella M; Boneschi FM; ; King C Pharmacogenomics J; 2017 Jul; 17(4):312-318. PubMed ID: 27001119 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic Potential of Combined Therapy of Vitamin A and Vitamin C in the Experimental Autoimmune Encephalomyelitis (EAE) in Lewis Rats. Navidhamidi M; Nazari A; Dehghan S; Ebrahimpour A; Nasrnezhad R; Pourabdolhossein F Mol Neurobiol; 2022 Apr; 59(4):2328-2347. PubMed ID: 35072933 [TBL] [Abstract][Full Text] [Related]
3. Influence of Genetic Polymorphisms on Clinical Outcomes of Glatiramer Acetate in Multiple Sclerosis Patients. Zarzuelo-Romero MJ; Pérez-Ramírez C; Cura Y; Carrasco-Campos MI; Marangoni-Iglecias LM; Ramírez-Tortosa MC; Jiménez-Morales A J Pers Med; 2021 Oct; 11(10):. PubMed ID: 34683173 [TBL] [Abstract][Full Text] [Related]
4. Piperine Improves Experimental Autoimmune Encephalomyelitis (EAE) in Lewis Rats Through its Neuroprotective, Anti-inflammatory, and Antioxidant Effects. Nasrnezhad R; Halalkhor S; Sadeghi F; Pourabdolhossein F Mol Neurobiol; 2021 Nov; 58(11):5473-5493. PubMed ID: 34338970 [TBL] [Abstract][Full Text] [Related]
6. An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response. Choi JH; Lee MJ; Jang M; Kim EJ; Shim I; Kim HJ; Lee S; Lee SW; Kim YO; Cho IH PLoS One; 2015; 10(10):e0138592. PubMed ID: 26444423 [TBL] [Abstract][Full Text] [Related]
7. Korean Red Ginseng and Ginsenoside-Rb1/-Rg1 Alleviate Experimental Autoimmune Encephalomyelitis by Suppressing Th1 and Th17 Cells and Upregulating Regulatory T Cells. Lee MJ; Jang M; Choi J; Chang BS; Kim DY; Kim SH; Kwak YS; Oh S; Lee JH; Chang BJ; Nah SY; Cho IH Mol Neurobiol; 2016 Apr; 53(3):1977-2002. PubMed ID: 25846819 [TBL] [Abstract][Full Text] [Related]
8. Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis. Byun E; Caillier SJ; Montalban X; Villoslada P; Fernández O; Brassat D; Comabella M; Wang J; Barcellos LF; Baranzini SE; Oksenberg JR Arch Neurol; 2008 Mar; 65(3):337-44. PubMed ID: 18195134 [TBL] [Abstract][Full Text] [Related]
9. Sieving treatment biomarkers from blood gene-expression profiles: a pharmacogenomic update on two types of multiple sclerosis therapy. Goertsches RH; Zettl UK; Hecker M Pharmacogenomics; 2011 Mar; 12(3):423-32. PubMed ID: 21449680 [TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomic update on multiple sclerosis: a focus on actual and new therapeutic strategies. Foti Cuzzola V; Palella E; Celi D; Barresi M; Giacoppo S; Bramanti P; Marino S Pharmacogenomics J; 2012 Dec; 12(6):453-61. PubMed ID: 23044601 [TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics of autoimmune diseases: research issues in the case of Multiple Sclerosis and the role of IFN-beta. Macciardi F; Martinelli Boneschi F; Cohen D J Autoimmun; 2005; 25 Suppl():1-5. PubMed ID: 16311019 [TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomics of interferon beta and glatiramer acetate response: a review of the literature. Mahurkar S; Suppiah V; O'Doherty C Autoimmun Rev; 2014 Feb; 13(2):178-86. PubMed ID: 24189284 [TBL] [Abstract][Full Text] [Related]